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After an individual’s exposure to a given
chemical, a proportion of the chemical may be
absorbed into the bloodstream, distributed
among the bodily tissues, metabolized, and/or
excreted. These four complex steps [i.e.,
absorption, distribution, metabolism, and
excretion (ADME)] make up the pharmaco-
kinetic process of a chemical (reviewed in
Rozman and Klaasen 2001). In order to assess
human exposure to a given chemical, biologic
measurements of the chemical can be made
after the absorption step or during each of the
subsequent steps of ADME. Biomonitoring of
exposure involves the measurement of the con-
centration of a chemical in a given biologic
matrix during or after ADME, and its concen-
tration level depends on the amount of the
chemical that has been absorbed into the body,
the pharmacokinetics (ADME) of the chemi-
cal, and the exposure scenario, including the
time sequence of exposure and time since last
exposure (Sexton et al. 1995). Biomonitoring
data are independent of the pathway of expo-
sure (Pirkle et al. 1995). Ideally, in order to
link the dose with adverse health outcomes,
measurements of the biologically effective
dose, the dose at the target site that causes an
adverse health effect, are preferred (Pirkle et al.
1995). However, often the target organ is not
known and, even if known, frequently is not
available for sampling. In these situations, we
measure the level of the chemical in another
biologic sample to gauge the internal dose.
For the National Children’s Study (NCS
2005), the biologic sample can be taken
preconceptionally from both parents; from a
pregnant woman during each of the three
trimesters, during and immediately after child-
birth; from the mother postnatally; and from
the child as it develops up to 21 years of age.
The appropriate sample for monitoring will
depend upon matrix availability and the differ-
ent classes of environmental chemicals to be
monitored. Under the auspices of the Chemical
Exposures Workgroup of the NCS, we devel-
oped this article as part of a larger white paper
(NCS 2004) to provide guidance on which
biologic samples may be most useful for charac-
terizing exposures of interest in the NCS.
Although this guidance may be applicable to
other exposure studies, it was developed with
the life stages of interest to the NCS and with
the recognition that the specimens available for
testing may be limited in volume or quantity
(Needham et al. 2004, 2005). Unless otherwise
stated, we refer to measurements made on bio-
logic samples from the parents or the child but
not from the fetus. Further, we focus primarily
on chemical measurements made in a biologic
matrix that is taken from the participant, a
commonly used strategy in human exposure
assessment. Although newer methodologies
such as imaging techniques and “omics” tech-
nology are becoming more readily available
(Chaussabel 2004; de Hoog and Mann 2004;
Dettmer and Hammock 2004; Kiechle et al.
2004; Olden 2004; Wetmore and Merrick
2004), they are not included in this article.
The General Behavior 
of a Chemical in the Body
Absorption of a chemical into the body occurs
when the chemical enters the bloodstream by
passing through absorption membrane barriers
after contact of the chemical with an outer
boundary (i.e., skin, nostrils, mouth, or eyes).
Without absorption, there can be no direct
internal toxic effect even if the chemical is
toxic, although effects are possible at the
absorption barrier (e.g., skin irritation, eye lens
irritation). Once the chemical has been
absorbed into the bloodstream, it undergoes
distribution to the primary deposition sites.
Distribution is crucial to toxicity because if the
chemical is never distributed to the target site,
the toxic effect may be negligible. The concen-
tration of the chemical in the storage depot is
in equilibrium with the concentration in the
blood, thus the chemical is slowly released
from the storage depot as it is eliminated from
the blood to maintain the equilibrium. Low
concentrations may reach the target organ.
Metabolism takes place primarily in the
liver. The overall purpose of metabolism is to
make the chemical less toxic and more
hydrophilic. Phase 1 metabolism of the chem-
ical typically involves inserting or substituting
a functional group to make the chemical more
water soluble. Phase 2 metabolism usually
chemically links the chemical to a glucuronide
or sulfate group, which increases the water
solubility and facilitates elimination of the
chemical in the urine. However, metabolism
does not always render a chemical less toxic.
Metabolized chemicals may be more
hydrophilic and can be excreted in urine or
may be passed into the feces. If the chemical
is not absorbed, it can go straight into the
feces. Lipophilic compounds, in particular,
are eliminated primarily in the feces. Volatile
organic compounds (VOCs) can be excreted
through the alveoli or in the expired air
through exhalation. Chemicals can also be
deposited in certain secretory structures and
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(2005). doi:10.1289/ehp.7617 available via http://dx.doi.org/ [Online 12 May 2005]be excreted as tears, saliva, sweat, or milk in
lactating women.
In addition to the internal movement of
chemicals in the body, a pregnant woman can
distribute the chemicals via the bloodstream
through the placenta and into the fetal blood
supply. Biomonitoring matrices unique to the
fetus include amniotic fluid and meconium.
In addition, cord blood, the placenta, and the
umbilical cord can be collected at birth.
Behavior of Speciﬁc Chemical
Classes in the Body
Persistent organic chemicals. Persistent organic
pollutants or chemicals (POPs) include poly-
chlorinated dibenzo-p-dioxins, polychlorinated
biphenyls (PCBs), and organochlorine insecti-
cides (Needham et al. 2005; United Nations
Environment Program 2001). Polycyclic aro-
matic hydrocarbons (PAHs) are also often
included in this class because they persist in the
environment; however, because PAHs behave
more like nonpersistent chemicals in the body,
we have chosen to exclude them from POPs
(Needham et al. 2005). The primary route of
exposure to POPs is ingestion. POPs are read-
ily absorbed into the blood supply by passive
diffusion. Their blood level initially decays
relatively rapidly, representing the alpha decay
period (Flesch-Janys et al. 1996). During the
alpha decay, the POP is distributed into the
fatty portions of tissues and, in lactating
women, in breast milk. The concentration of
the POP in the fatty portions of tissues is in
equilibrium with the concentration in the lipid
portion of blood. The fat content of blood
serum is 0.5–0.6%, milk is approximately 4%
lipid, and adipose tissue may be as much as
95% lipid. Thus, although the equilibrium
concentrations of the chemical in the blood
and fatty tissues may differ over orders of mag-
nitude, they may be very similar when matrices
are adjusted for lipid content.
In pregnant women, the POP may also
distribute in the fetal compartment; therefore,
other matrices such as cord blood or serum
may be used for POP measurements.
However, the lipid content of cord blood is
lower than that of an adult’s blood, so the sen-
sitivity of the analytical measurement may
play a key role in obtaining a valid measure-
ment in cord blood. Other fetal matrices, such
as meconium, have not been fully explored for
their potential in assessing POP exposures in
the fetus. Maternal blood or adipose tissue
taken before or during pregnancy and mater-
nal blood, milk, or adipose tissue taken soon
after parturition (if breast-feeding or can be
taken later if not breast-feeding) are consid-
ered the best matrices for estimating fetal
exposures to POPs.
Because metabolism and excretion of
POPs are very slow, they have a long half-life
in the body, usually along the order of years
(Michalek et al. 1996; Phillips et al. 1989b).
However, because the lipophilic POPs accu-
mulate in the breast milk of lactating women
and the milk is removed from the woman’s
body, the half-life of POPs in lactating women
is about 6 months (LaKind et al. 2000).
Nonpersistent organic chemicals.
Nonpersistent organic chemicals, such as
current-use pesticides, phthalates, and VOCs
(Needham et al. 2005), can be much more
challenging to measure. Their primary routes
of exposure for the general population,
depending on the scenario, are generally inges-
tion or inhalation. These chemicals are rapidly
metabolized, and their metabolites are elimi-
nated in urine (Figure 1). The deposition
matrices are minor matrices for monitoring
because only small amounts of the chemical are
deposited in the body. The major matrices for
assessing exposure are excreta. Blood has also
been used as a matrix for biomonitoring.
Nonpersistent chemicals tend to have very
short half-lives in blood (Figure 1), and the
concentrations are usually about three orders of
magnitude lower than urinary metabolite levels
(Barr et al. 1999). Thus, if blood is used as a
matrix, the sensitivity of the analytical method
and the matrix volume available for analysis
may become important. Blood can also be a
valuable matrix for measuring biomolecular
adducts such as hemoglobin, albumin, or
DNA adducts, such as DNA–PAH adducts.
Saliva has also been explored as a matrix
for measuring selected nonpersistent chemi-
cals such as atrazine (Lu et al. 1998). The
existing data indicate that saliva levels can be
considerably lower than blood levels of a non-
persistent chemical depending upon the
degree of protein binding that may occur;
thus, a very sensitive analytical technique is
required. Further research on additional
chemicals and the relation of these measure-
ments to more commonly used approaches
is required before this can routinely be used
for analysis.
To evaluate fetal exposures, maternal sam-
ples collected throughout pregnancy may be
used. However, because these chemicals are,
by definition, nonpersistent, urine or blood
measurements made at a single point in time
during pregnancy will address only the expo-
sures that may have occurred in the previous
few days unless the exposure is continuous
(e.g., pervasive air levels of a chemical resulting
from smokers in the home) or continual (e.g.,
eating the same foods daily with measurable
levels of pesticides) (Figure 2). To circumvent
this problem, multiple biologic samples can be
taken every few days during pregnancy; how-
ever, this can be costly and logistically difﬁcult
to collect and store and may present an undue
burden on the participant. An alternative may
be to collect multiple samples over particularly
vulnerable stages of the pregnancy, if such
stages can be appropriately identiﬁed. Another
potential approach is to measure nonpersistent
chemicals in fetal matrices such as cord blood
or meconium.
Bioaccumulative metals. Bioaccumulative
metals persist in the environment and bio-
accumulate in humans. This group of chemi-
cals includes some forms of mercury, lead, and
cadmium (Needham et al. 2005). For example,
lead is readily absorbed, particularly in chil-
dren, with distribution from the blood to its
storage depots—bone and teeth (Aufderheide
and Wittmers 1992). Both metabolism and
excretion are slow, so monitoring lead levels is
more straightforward. The best matrices to use
are blood, bone, and teeth. For general popula-
tion exposures to mercury, methyl mercury is
the form of highest concern. Blood, hair, and
Barr et al.
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Figure 1. Hypothetical postexposure fate of a nonpersistent toxicant in blood and urine. Reproduced from
Needham and Sexton (2000) with permission of Nature Publishing.
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Nonbioaccumulative metals. Non-
bioaccumulative metals are readily absorbed
into the body, and although some proportion
may distribute to various tissues, most will pass
through the body rapidly. These metals are
typically measured in urine (Horng et al.
1999). However, to gain a longer term dosime-
ter for exposure, arsenic can also be measured
in hair (Wilhelm and Idel 1996) and nails (Lin
et al. 1998).
Criteria pollutants and bioallergens. In
general, biomonitoring has a limited role in the
measurement of criteria pollutants [e.g., carbon
monoxide (CO), oxides of nitrogen, ozone]
and bioallergens (e.g., pollen, endotoxins)
(Needham et al. 2005). Exposure to CO can
be assessed by measuring the carboxyhemoglo-
bin adduct (Shenoi et al. 1998; Smith et al.
1998) or expired CO (Lapostolle et al. 2001;
Paredi et al. 2002) in blood and breath, respec-
tively. The adduct measurements provide a
longer-term dosimeter for the exposure than
breath measurements because hemoglobin has
a lifetime of about 4 months.
Bioallergen response can be measured by
IgE in maternal, cord blood, or child blood
(Carrer and Moscato 2004; Goodman and
Leach 2004; Lee et al. 2004). In addition, cer-
tain endotoxins or metabolites may be meas-
ured in blood or urine samples (Makarananda
et al. 1998; Malir et al. 2004). Typically,
the endotoxin measurements would reflect a
more recent exposure, similar to nonpersistent
chemical exposures.
Assessing Exposure
throughout the Life Cycle
Biomonitoring measurements have been used
for many years to assess exposures in adults
(Ashley et al. 1994; Blount et al. 2000; CDC
2003; Pirkle et al. 1995) and, to some extent,
in adolescents and children (Adgate et al.
2001; Fenske et al. 2000). Biomonitoring of
fetuses, infants, and small children has been
performed much less frequently, if at all.
Various biologic matrices have been used or
considered for assessing environmental expo-
sures throughout the life cycle (Table 1). The
mother or pregnant woman has generally been
used as a surrogate to evaluate fetal exposures.
However, for many chemicals, their ability to
transfer from the mother to the fetus is not
known and the relationship between maternal
and fetal chemical levels has not been deﬁned.
Another potential option to evaluate fetal
exposures is the use of meconium as a matrix
of measurement because it begins accumulat-
ing in the bowels of the infant during the sec-
ond trimester (Bearer 2003; Bearer et al. 2003;
Ostrea et al. 1994). However, meconium use
has many limitations. Meconium measure-
ments are still in their infancy of development,
and to date, no reliable way to relate these
measurements to measurements in more com-
monly used matrices (e.g., urine, blood) exists.
In addition no information is gleaned from
exposures that occurred in the ﬁrst trimester.
However, many meconium measures have
been shown to correlate well with reported
maternal exposures to tobacco (Ostrea et al.
1994), drugs of abuse (Ostrea 1999), and
alcohol consumption (Bearer et al. 2003), and
this matrix shows promise for other chemical
exposures of concern (Whyatt and Barr 2001).
The period from birth through 1 year of
age is also very important (Needham and
Sexton 2000; Needham et al. 2004, 2005).
During this time the infants may be breast-
feeding, so they may be exposed to chemicals
via breast milk. In addition their micro-
environments are often close to the ﬂoor and
substantially different from an older child or
adults. At this age probably only urinary
chemical measurements and breast milk meas-
urements can be made. Urine volume will
likely be limited, usually 10 mL or less.
Once children start school, another envi-
ronment with potential chemical contamina-
tion is included in the exposure scenario;
however, biologic sample collections become
easier. At this stage in life some blood can be
collected, but it is often limited to a small
amount. Urine and saliva samples also can be
readily collected. As children approach adoles-
cence and adulthood, more biologic samples
and/or a greater quantity of a matrix can be
collected. At this life stage perhaps up to
100 mL of blood can be collected for various
measurements, and urine is typically plentiful.
Biologic Matrices for Exposure
Assessment
The two primary matrices used to assess
human exposure to chemicals are urine and
blood (serum, plasma, blood cells, etc.) (Barr
et al. 1999; Needham and Sexton 2000; Pirkle
et al. 1995).
Blood. Many persistent and nonpersistent
chemicals can be measured in blood (Angerer
1988; Angerer and Horsch 1992; Barr et al.
2002; Leng et al. 1997). Although the
amount of blood is similar in all adults, the
chemical composition of blood, such as lipid
content, varies between individuals and
within an individual, especially postprandial
(Phillips et al. 1989a). Blood concentrations
of lipophilic chemicals are routinely normal-
ized using blood lipid concentrations to allow
a direct comparison of their concentrations
within and among individuals, regardless of
the time of day the blood was collected.
However, other chemicals that can be meas-
ured in blood may not vary based upon the
blood lipid content. For example, ﬂuorinated
chemicals in blood are not dependent upon
the lipid content; instead, they bind to blood
albumin (Jones et al. 2003). Therefore, these
measurements should not be adjusted based
upon the blood lipid content; however, other
adjustments, such as for albumin content,
may be required if deemed appropriate.
Measuring a chemical in blood is inher-
ently advantageous (Barr et al. 1999). Because
we know how much blood is in the body, we
can calculate the body burden more accurately
than if we measure the chemical or its metabo-
lite in urine. However, blood collection is inva-
sive, which may severely limit the ability to
collect it from infants and small children. In
addition nonpersistent chemicals are usually
found in very low concentrations in blood
(Barr et al. 1999, 2002). Also, if testing is not
performed soon after sample collection, which
will likely be the case in the NCS, long-term
storage of blood may be problematic, depend-
ing upon what form of blood is being stored.
Storage conditions and stability of various
matrices and chemicals are shown in Table 2.
Urine. One major advantage of using urine
in biomonitoring is the ease of its collection
for spot urine samples (Barr et al. 1999;
Needham et al. 2004); however, the collection
of 24-hr urine voids can be very cumbersome
and result in nonadherence (Kissel et al. 2005).
Therefore, spot urine samples, whether ﬁrst-
morning voids or “convenience” samplings, are
most generally used for biomonitoring pur-
poses. The major disadvantages of spot urine
samples include the variability of the volume of
urine and the concentrations of endogenous
and exogenous chemicals from void to void
(Barr et al. 1999; Kissel et al. 2005). The issue
on how best to adjust the urinary concentra-
tions of environmental chemicals in a manner
analogous to the adjustment of the concentra-
tions of lipophilic chemicals in blood is a sub-
ject of continued research. Adjustment using
urinary creatinine concentrations [i.e., dividing
the analyte concentration by the creatinine
concentration (in grams creatinine per liter
urine)] is the most routinely used method for
correcting for dilution. Analyte results are then
reported as weight of analyte per gram of
creatinine (e.g., micrograms analyte per gram
creatinine). This may work well when compar-
ing analyte levels in a single individual because
Biomonitoring during the life stages
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Figure 2. Hypothetical postexposure fate from
chronic exposure to a nonpersistent toxicant in
blood and urine.
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populations the interindividual variation is
extremely high (Barr et al. 2005).
Breast milk and adipose tissue. Many of
the chemicals measured in blood have been
found in breast milk (LaKind et al. 2001) and
adipose tissue (Patterson et al. 1987). Breast
milk measurements are unique in that they
not only provide data on ingestion exposures
for the infant but also are indicators of mater-
nal exposures. Breast milk and adipose tissue
are lipid-rich matrices, more so than blood, so
similar lipid adjustments are required for
reporting concentrations of lipophilic analytes.
In general these lipophilic analytes partition
among the lipid stores in blood, breast milk,
and adipose tissue on nearly a 1:1:1 basis
(Patterson et al. 1987). More laboratory work
needs to be done on the partitioning of less
bioaccumulative analytes in these matrices.
Barr et al.
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Table 1. Importance of various biologic matrices for measuring exposure during the different life stages. 
Continued, next page
Adult pre-  Fetal period (trimester) Age (years)
Matrices conception 1st 2nd 3rd 0–1 2–3 4–11
POPs
Blood (whole) 1 NA NA NA 1 1 1
Blood (serum) 1 NA NA NA 1 1 1
Blood (plasma) 1 NA NA NA 1 1 1
Urine 3 NA NA NA 3 3 3
Saliva 3 NA NA NA NA 3 3
Hair 3 NA NA NA 3 3 3
Nails 3 NA NA NA 3 3 3
Adipose tissue 1 NA NA NA NA NA NA
Feces 3 NA NA NA 3 3 3
Semen 3 NA NA NA NA NA NA
Breath 3 NA NA NA NA 3 3
Teeth NA NA NA NA NA NA 3
Cord blood 1 1 1 1 3 3 3
Meconium 3 2 2 2 3 3 3
Milk (maternal) 1 1 1 1 1 3 3
Blood (maternal) 1 1 1 1 1 3 3
Urine (maternal) 3 3 3 3 3 3 3
Hair (maternal) 3 3 3 3 3 3 3
Adipose tissue (maternal) 1 1 1 1 1 3 3
Nonpersistent organic chemicals
Blood (whole) 1 NA NA NA 1 1 1
Blood (serum) 1 NA NA NA 1 1 1
Blood (plasma) 1 NA NA NA 1 1 1
Urine 1 NA NA NA 1 1 1
Saliva 2 NA NA NA NA 2 2
Hair 3 NA NA NA 3 3 3
Nails 3 NA NA NA 3 3 3
Adipose tissue 3 NA NA NA NA NA NA
Feces 3 NA NA NA 3 3 3
Semen 3 NA NA NA NA NA NA
Breath 3 NA NA NA NA 3 3
Teeth 3 NA NA NA NA NA 3
Cord blood 3 3 3 1 3 3 3
Meconium 3 3 2 2 3 3 3
Milk (maternal) 3 3 3 3 2 3 3
Blood (maternal) 3 1 1 1 3 3 3
Urine (maternal) 3 1 1 1 3 3 3
Hair (maternal) 3 3 3 3 3 3 3
Adipose tissue (maternal) 3 3 3 3 3 3 3
VOCs
Blood (whole) 1 NA NA NA 1 1 1
Blood (serum) 3 NA NA NA 3 3 3
Blood (plasma) 3 NA NA NA 3 3 3
Urine 2 NA NA NA 2 2 2
Saliva 3 NA NA NA NA 3 3
Hair 3 NA NA NA 3 3 3
Nails 3 NA NA NA 3 3 3
Adipose tissue 2 NA NA NA NA NA NA
Feces 3 NA NA NA 3 3 3
Semen 3 NA NA NA NA NA NA
Breath 1 NA NA NA NA 1 1
Teeth 3 NA NA NA NA NA 3
Cord blood 3 3 3 1 3 3 3
Meconium 3 3 3 3 3 3 3
Milk (maternal) 3 3 3 3 2 3 3
Blood (maternal) 3 1 1 1 3 3 3
Urine (maternal) 3 3 3 3 3 3 3
Hair (maternal) 3 3 3 3 3 3 3
Adipose tissue (maternal) 3 3 3 3 3 3 3
Adult pre-  Fetal period (trimester) Age (years)
Matrices conception 1st 2nd 3rd 0–1 2–3 4–11
Bioaccumulative inorganic chemicals
Blood (whole) 1 NA NA NA 1 1 1
Blood (serum) 3 NA NA NA 3 3 3
Blood (plasma) 3 NA NA NA 3 3 3
Urine 2 NA NA NA 2 2 2
Saliva 3 NA NA NA NA 3 3
Hair 2 NA NA NA 2 2 2
Nails 2 NA NA NA 2 2 2
Adipose tissue 3 NA NA NA NA NA NA
Feces 3 NA NA NA 3 3 3
Semen 3 NA NA NA NA NA NA
Breath 3 NA NA NA NA 3 3
Teeth 3 NA NA NA NA NA 2
Cord blood 2 2 2 1 3 3 3
Meconium 3 2 2 2 3 3 3
Milk (maternal) 3 3 3 3 3 3 3
Blood (maternal) 1 1 1 1 3 3 3
Urine (maternal) 3 2 2 2 3 3 3
Hair (maternal) 2 2 2 2 3 3 3
Adipose tissue (maternal 3 3 3 3 3 3 3
Nonbioaccumulative inorganic chemicals
Blood (whole) 3 NA NA NA 3 3 3
Blood (serum) 3 NA NA NA 3 3 3
Blood (plasma) 3 NA NA NA 3 3 3
Urine 1 NA NA NA 1 1 1
Saliva 3 NA NA NA NA 3 3
Hair 2 NA NA NA 2 2 2
Nails 2 NA NA NA 2 2 2
Adipose tissue 3 NA NA NA NA NA NA
Feces 3 NA NA NA 3 3 3
Semen 3 NA NA NA NA NA NA
Breath 3 NA NA NA NA 3 3
Teeth 3 NA NA NA NA NA 3
Cord blood 3 3 3 3 3 3 3
Meconium 3 3 3 3 3 3 3
Milk (maternal) 3 3 3 3 3 3 3
Blood (maternal) 3 3 3 3 3 3 3
Urine (maternal) 3 1 1 1 3 3 3
Hair (maternal) 2 2 2 2 3 3 3
Adipose tissue (maternal) 3 3 3 3 3 3 3
Criteria pollutants (CO only)
Blood (whole) 1 NA NA NA 1 1 1
Blood (serum) 3 NA NA NA 3 3 3
Blood (plasma) 3 NA NA NA 3 3 3
Urine 3 NA NA NA 3 3 3
Saliva 3 NA NA NA NA 3 3
Hair 3 NA NA NA 3 3 3
Nails 3 NA NA NA 3 3 3
Adipose tissue 3 NA NA NA NA NA NA
Feces 3 NA NA NA 3 3 3
Semen 3 NA NA NA NA NA NA
Breath 1 NA NA NA NA 1 1
Teeth 3 NA NA NA NA NA 3
Cord blood 3 3 3 1 3 3 3
Meconium 3 3 3 3 3 3 3
Milk (maternal) 3 3 3 3 3 3 3
Blood (maternal) 3 1 1 1 3 3 3
Urine (maternal) 3 3 3 3 3 3 3
Hair (maternal) 3 3 3 3 3 3 3
Adipose tissue (maternal) 3 3 3 3 3 3 3Alternative matrices. Chemicals have
been successfully measured in alternative
matrices such as saliva (Bernert et al. 2000;
Lu et al. 1998), meconium (Bearer et al.
1999, 2003; Ostrea 1999; Ostrea et al. 1994;
Whyatt and Barr 2001), amniotic fluid
(Bradman et al. 2003; Foster et al. 2002),
and breath (Pellizzari et al. 1992). Because
many of these matrices are not commonly
analyzed, the resulting chemical concentra-
tion data are more difﬁcult to relate to meas-
urements made in the more commonly used
matrices such as urine, blood, or breast milk
and, consequently, may be more difficult to
relate to exposure. However, because many
of these matrices are available and could
provide potentially useful information, they
should not be discounted. Instead, prelimi-
nary studies evaluating the partitioning of
chemicals in the various matrices should be
conducted that will allow for comparison of
data among matrices.
Measurement method speciﬁcity and sen-
sitivity requirements. Specificity—how spe-
cific an analysis method is for a particular
exposure—and sensitivity—the ability to
measure the chemical at the desired level—are
critical parameters for analysis methods, and
both must be considered when deciding
which matrix to measure. The half-life of a
chemical may affect the sensitivity require-
ment; however, because persistent chemicals
have long half-lives, it is not nearly as impor-
tant as it is for nonpersistent chemicals, which
metabolize rapidly. For instance, in adult
men, 2,3,7,8-tetrachlorodibenzo-p-dioxin has
a half-life of about 7.6 years (Pirkle et al.
1989). Therefore, to assess exposure over a
period of time, for example, 9 months, the
sample could be collected at any time period
within the 9 months or even afterward, and
the biologic measurement information would
still be useful for accurate exposure classiﬁca-
tion (e.g., exposure quartiles—people whose
exposure is high, medium, low, or none).
Biomonitoring during the life stages
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Table 1. Continued
Abbreviations: 1, important matrix for most chemicals in category; 2, important matrix for one or two chemicals in category; 3, not an important matrix for assessing exposure for chemi-
cals in the category; NA, matrix not viable for life stage because it cannot be feasibly collected or the chemical cannot typically be measured in the matrix or does not represent expo-
sures in a given life stage; *, unknown amount. Note that matrices available for assessment in 12- to 21-year-olds are similar to those for adults.
aAll units are in milliliters unless otherwise stated.
Adult pre-  Fetal period (trimester) Age (years)
Matrices conception 1st 2nd 3rd 0–1 2–3 4–11
Bioallergens
Blood (whole) 1 NA NA NA 1 1 1
Blood (serum) 1 NA NA NA 1 1 1
Blood (plasma) 1 NA NA NA 1 1 1
Urine 2 NA NA NA 2 2 2
Saliva 3 NA NA NA NA 3 3
Hair 3 NA NA NA 3 3 3
Nails 3 NA NA NA 3 3 3
Adipose tissue 3 NA NA NA NA NA NA
Feces 3 NA NA NA 3 3 3
Semen 3 NA NA NA NA NA NA
Breath 3 NA NA NA NA 3 3
Teeth 3 NA NA NA NA NA 3
Cord blood 3 1 1 1 3 3 3
Meconium 3 3 3 3 3 3 3
Milk (maternal) 3 3 3 3 3 3 3
Blood (maternal) 3 1 1 1 3 3 3
Urine (maternal) 3 2 2 2 3 3 3
Hair (maternal) 3 3 3 3 3 3 3
Adipose tissue (maternal) 3 3 3 3 3 3 3
Adult pre-  Fetal period (trimester) Age (years)
Matrices conception 1st 2nd 3rd 0–1 2–3 4–11
Amount of matrix reasonably obtainable at each life stagea
Blood (whole) 100 0 0 0 9 22 38
Blood (serum) 40 0 0 0 3.6 8.8 15.2
Blood (plasma) 40 0 0 0 3.6 8.8 15.2
Urine >100 0 0 0 1–10 10–20 30–50
Saliva 2 0 0 0 0 1–2 1–2
Hair 0.5–4 g 0 0 0 < 0.5 g 0.5–2g 0.5–4g
Nails * 0 0 0 * * *
Adipose tissue 10 g 0 0 0 0 0 0
Feces 10 g 0 0 0 3 g 5 g 1 0g
Semen 2 0 0 0 0 0 0
Breath * 0 0 0 * * *
Teeth 0 0 0 0 0 0 6–10
Cord blood 30–60 30–60 30–60 30–60 NA NA NA
Meconium 2 g 2 g 2 g 2 g NA NA NA
Milk (maternal) >100 >100 >100 >100 >100 NA NA
Blood (maternal) 100 100 100 100 100 100 100
Urine (maternal) >100 >100  >100 >100  >100 >100 >100
Hair (maternal) * * * * * * *
Adipose tissue (maternal) 10 g 10 g 10 g 10 g 0 0 0
Table 2. Storage requirements and characteristics for biologic matrices and chemical classes.
Storage Matrix Chemical Preservative
Chemical class Chemicals temperature Matrix stability stability Container requirements
POPs All –70ºC Milk Years Years Polypropylene, no glass  NA
or Teﬂon
All –70ºC Serum/plasma Years Years Polypropylene, no glass 
or Teﬂon NA
All –70ºC Adipose tissue Years Years Polypropylene, no glass 
or Teﬂon NA
Nonpersistent  All –70ºC Urine Years Years Polypropylene or glass NA
organic compounds Phthalates –70ºC Serum/plasma Years Years Polypropylene or glass 125 µmol H3PO4/mL
matrix
Pesticides –70ºC Serum/plasma ~ 5 years Up to 1 year (less Polypropylene or glass None
for many of the
reactive pesticides)
Others –70ºC Serum/plasma Years Years Polypropylene or glass NA
VOCs 4°C Whole blood 10 weeks > 10 weeks Heat and vacuum-purged NaF/ potassium
glass gray-top Vacutainer; oxalate
restore sterility
Bioaccumulative metals 4°C Whole blood Indeﬁnitely Indeﬁnitely Purple-top liquid EDTA NA
Vacutainer; second or 
third draw
Nonbioaccumulative –20ºC Urine Indeﬁnitely Indeﬁnitely Prescreened For Hg, Triton X-100, 
metals sulfamic acid
Room temperature Hair Indeﬁnitely Indeﬁnitely Zipper bag NAWhen measuring exposure to persistent
chemicals by analyzing adipose tissue, it
makes little difference which portion of the
body the sample is taken from; however,
because blood is easy to collect and readily
available, blood is an ideal medium in which
to measure persistent chemicals. In lactating
women, milk is also frequently used.
Nonpersistent chemicals have half-lives of
hours or minutes; therefore, the postexposure
fate of a nonpersistent chemical is dramatically
different (Figure 1) (Needham and Sexton
2000). After each exposure the concentration
of the chemical in blood declines rapidly. The
window of opportunity for measuring non-
persistent chemicals in blood is narrow and
requires the use of a very sensitive technique.
By measuring these chemicals in blood as the
intact, or parent, chemical, we gain informa-
tion on the exact chemical to which one was
exposed. For example, if someone was exposed
to chlorpyrifos, we can measure chlorpyrifos
in the blood rather than its metabolite, which
is formed from more than one parent chemi-
cal and is also the same chemical as environ-
mentally degraded chlorpyrifos. In addition to
blood, certain nonpersistent chemicals such as
cotinine have been measured in saliva because
cotinine is in equilibrium in blood and saliva.
In urine we generally measure metabolites
of the chemical that may lack the desired
speciﬁcity for analysis; however, measurements
in urine allow a much wider window of
opportunity in which to take the sample.
Generally, we assess exposure to nonpersistent
chemicals by measuring their metabolites in
urine, even though this method may not have
the speciﬁcity of the blood measurement.
When chronic exposure to a nonpersistent
chemical occurs, the exposure is continually
replenishing the chemical in the blood and
urinary elimination may reach a steady state.
Therefore, urine becomes a better matrix for
measurement because we integrate exposure
over a longer period.
Biomolecular adducts. Persistent and non-
persistent chemicals can also react with bio-
molecules such as DNA, hemoglobin, or fatty
acids to form biomolecular adducts (Angerer
et al. 1998; Schettgen et al. 2002). By measur-
ing these adducts, we are able to increase the
amount of time after exposure that we can
measure a nonpersistent chemical because the
amount of time the adduct remains in the
body is largely dependent upon the lifetime of
the biomolecule itself (Needham and Sexton
2000). For example, the average life span of a
red blood cell is about 120 days. If a chemical
formed an adduct with hemoglobin on the
day a red blood cell was created, the adduct
should remain in the body about 4 months,
allowing a much longer time after exposure to
collect the sample. Other adducts are formed
with DNA, albumin, and other prominent
proteins. Because adducts are not formed from
every chemical molecule to which one is
exposed, adduct measurements must be very
sensitive, and usually a large amount of matrix
is required. In addition the measurements are
usually cumbersome and time-consuming, so
the analytical throughput is very low and the
cost is very high.
When measuring persistent chemicals, we
do not gain much advantage by measuring
them as adducts. Blood is still the matrix of
choice because the concentration is higher in
blood, and we have a wide window of opportu-
nity (Barr and Needham 2002). To form an
adduct, the chemical must have an electrophilic
site to which a nucleophile on the biomolecule
(usually sulfur or nitrogen) can covalently bind.
Sampling time frame. For persistent
organic chemicals, the time frame for sampling
is reasonably straightforward. In general, a
blood sample can be taken any time, up to sev-
eral years after exposure, has occurred and the
exposure can still be accurately identiﬁed; how-
ever, the investigator will not have any infor-
mation about when the exposure occurred. For
example, if a PCB concentration of 1,000 ng/g
lipid was measured in a blood sample, it is not
known if a recent exposure to this amount of
PCB occurred or whether a larger exposure
occurred many years ago and, although a por-
tion of the PCB has been eliminated from the
body over time, this amount is still circulating
in the bloodstream. By coupling questionnaire
data with these biologic measurements, investi-
gators may gain information on the timing of
the exposure (e.g., breast-feeding, subsistence
food consumption).
The sampling time frame for nonpersistent
chemicals is not straightforward. Because these
chemicals have short biologic half-lives, the
samples, whether blood or urine, must be col-
lected soon after the exposure in order to
appropriately assess the exposure. If the primary
exposure medium is the air and the exposure is
continuous, a ﬁrst-morning-void urine sample
is probably the best biologic sample for measur-
ing the exposure. However, if the exposure is
from a source related to personal grooming
(e.g., VOCs from showers or phthalates from
personal care products), a ﬁrst-morning-void
urine sample or an early morning blood sample
(before showering) would likely miss the expo-
sure from the next day. Rather, a late morning
or early afternoon sample would more accu-
rately characterize the daily exposure to these
chemicals. Similarly, samples designed to evalu-
ate dietary exposures, such as pesticides, should
be collected several hours after mealtimes so
that these exposures can be identiﬁed.
In general, sample collection for nonper-
sistent chemical measurements should reﬂect
the residence time of the chemical in each
individual matrix. The half-lives of nonpersis-
tent chemicals in blood are typically much less
than in urine samples; thus, blood samples
may need to be collected within minutes or
hours after the exposure, whereas urine sam-
ples may be collected several hours or in some
instances days after the exposure. Saliva sam-
ples will typically mimic blood, whereas meco-
nium samples may provide a longer window
for capturing the exposure. Measurements of
biomolecular adducts need to consider the
lifetime of the biomolecule, rather than the
lifetime of the chemical, in the particular
matrix; however, more adduct will likely be
present immediately after exposure than
several weeks after exposure.
Collecting samples from infants and chil-
dren. Difﬁculty is often encountered when col-
lecting urine samples from infants and children
who are not toilet trained. The traditional
approach is similar to that in a clinical setting,
using an infant urine collection bag. This tech-
nique is rather straightforward; however, it is
usually bothersome to the child and often
requires that the child be given liquids to
encourage urination within a given time frame.
Encouraging urination with drinks will usually
dilute the urine and make the analytical meas-
urement more difﬁcult. Other approaches for
urine collection, primarily from cloth diapers
or cotton inserts, have also been investigated
(Calafat et al. 2004; Hu et al. 2000). Another
approach of ongoing investigation is the collec-
tion of the target analytes directly from the
coagulated gel matrix of disposable diapers
(Hu et al. 2004). If proven viable for isolating
a broad array of target analytes, this method of
collection would be most attractive because it is
the least burdensome on the participant and
the most logistically practical.
Temporal variability in urine and blood
samples. The variability of nonpersistent target
analyte levels in samples collected from an
individual over time is of concern, whether the
sample is biologic or environmental. Temporal
variability can include the variation of a given
chemical in multiple samples collected on a
single day or can include variation among days,
months, or seasons. For chronic exposures to
nonpersistent chemicals, the exposure is
repeated; thus, the amount in a given sample
would likely represent the average exposure.
However, for episodic exposures, the variability
is often greater. For urine matrix, a 24-hr urine
sample is preferred; however, this can be bur-
densome on the participant and often
logistically difﬁcult. If a 24-hr sample cannot
be obtained, a ﬁrst-morning void is often pre-
ferred because the urine is more concentrated
and the collection represents a longer window
of accumulation (usually > 8 hr). However, a
ﬁrst-morning collection may not be ideal for
certain exposures because the timing for cap-
turing the exposure is “off.” For evaluation of
daily, monthly, and/or seasonal variations of
analyte in urine, sequential samples are often
Barr et al.
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taken days and weeks apart to evaluate how the
intraindividual variation over time compares
with the interindividual variation and whether
an accurate classiﬁcation of exposure is possi-
ble. These studies are important in interpreting
the biomonitoring data and should be consid-
ered, at some level, in the NCS. These data
will help to determine whether multiple sam-
ples should be taken and at what intervals. In
most instances sampling for nonpersistent
chemicals will require multiple samples taken
at regular intervals.
Methodology
Organic chemicals. Most methods for measur-
ing organic chemicals in biologic matrices use
a sample preparation step to isolate the target
chemical(s) from the matrix, an analytical
technique with a detection system, data pro-
cessing, and quality assurance (QA) processes
(Needham et al. 2005).
The sample preparation steps are usually
the most common source of analytic error,
whether systematic or random (Barr et al.
1999). If the chemical is inherently incompati-
ble with the analytic system that follows, a
chemical derivatization or reduction procedure
may also be required. The addition of steps into
the sample preparation procedure usually
increases the overall imprecision of the method.
Common analytical techniques for separa-
tion of individual chemicals include gas
chromatography, high-performance liquid
chromatography, or capillary electrophoresis
that are coupled in-line to a detection system.
Common detection systems include mass
spectrometry (MS), electron capture, flame
photometric, nitrogen phosphorus, fluor-
escence, and ultraviolet (UV) absorbance
detection. Of the detection systems, mass spec-
trometers provide the most speciﬁcity, and UV
absorbance detection usually provides the least
(Barr et al. 1999). Most MS-based methods
have limits of detection (LODs) in the range of
picograms to nanograms per gram of matrix,
typically adequate enough to detect levels in
the general population when 1–10 g of matrix
is used (Table 3). The analytical imprecision
usually ranges from 10 to 20%.
Other analytic techniques that are often
employed with organic chemicals are immuno-
assays and bioassays (Biagini et al. 1995; Brady
et al. 1989). For these techniques a sample
preparation step to isolate the chemical from
the matrix may or may not be used. Many are
commercially available for selected chemicals.
However, their development for a new chemi-
cal is a lengthy process that typically requires
the generation and isolation of antibodies, then
the development of the assay itself. Usually
UV, ﬂuorescence, or radioactivity detection is
used for the assays. They may be very speciﬁc
for a given chemical, or they may have a great
deal of cross-reactivity that may limit their util-
ity. Their LODs can vary widely; however,
many have adequate sensitivity for measuring
levels in the general population.
Because organic chemicals are measured
using expensive instrumentation and require
highly trained analysts, these measurements
are usually costly. The most selective and sen-
sitive methods are usually the most complex
and can range in cost from $100 to $1500
per sample analyzed (Table 3). However,
many of the analyses are multianalyte panels,
so the cost per analyte per sample is much
more reasonable. Generally, immunoassays
are less specific and less complex; therefore,
their cost is usually less than $50 per test.
However, usually only one chemical can be
measured per test, and new chemicals cannot
be easily incorporated into the method.
Inorganic chemicals. The sample prepara-
tion process for inorganic chemicals is typically
much simpler than for organic chemicals. In
some instances the sample matrix just needs to
be diluted with water before analysis. However,
special precautions must be taken to avoid con-
tamination, both preanalytically and in the
analytic system. For example, prescreened
collection materials should be used for sample
collection, all analytic supplies should be appro-
priately free of the target chemicals, and special
clean rooms may be required for analysis.
Inorganic chemicals are usually measured
using atomic absorption spectrometry (AAS)
or inductively coupled plasma (ICP) MS. In
some instances a dynamic collision cell may
also be used to eliminate potentially interfer-
ing salts from the system. When various forms
of inorganic chemicals are speciated, such as
for arsenic or mercury, the AAS or ICP–MS
will be preceded in-line by some chromato-
graphic unit. For lead screening an efficient
portable lead analyzer can be used for in-ﬁeld
measurements.
Similar to organic chemicals because
expensive instrumentation is used, the analy-
ses are usually costly, ranging from $50 for
single chemicals to $250 for multichemical
panels (Table 3). The LODs are comparable
with those of organic chemicals and are suit-
able for general population studies. Because
the handling of the sample is usually minimal,
the precision is usually better, within 5–10%.
Quality assurance and quality control. A
vital component of all biomonitoring
methodology is a sound quality assurance/
quality control (QA/QC) program. QA/QC
programs typically require strict adherence to
protocols and multiple testing procedures that
easily allow the detection of systematic fail-
ures in the methodology. The requirements
for QA/QC are described in detail in
Needham et al. (2005).
Conclusions
As a part of the NCS, many researchers will be
competing for the matrices available for bio-
logic measurements. We should reﬁne existing
methodology to include as many chemicals as
possible using as little blood or urine as possi-
ble. In addition we should investigate ways
to use more readily available, less invasive
matrices. We must consider all matrices and
Table 3. Characteristics of analytical methods for measuring chemical classes in biologic matrices.
Detection limits Relative  Throughput Volume
Chemical class Most typical matrices Methodology used (per gram) SD (%) (samples/day) for analysis Costa
POPs Blood (serum or plasma) GC-HRMS fg–pg 15–25 20 2–30 mL H
Milk GC-HRMS fg–pg 15–25 20 2–30 mL H
Adipose tissue GC-HRMS fg–pg 15–25 10 1–2 g H
Nonpersistent organic  Blood (serum or plasma) GC-HRMS; HPLC-MS/MS pg–ng 10–20 30 2–10 mL H
chemicals Urine GC-MS/MS; HPLC-MS/MS; immunoassay pg–ng 10–15 50 1–4 mL L–M
Saliva GC-HRMS; GC-MS/MS; HPLC-MS/MS pg–ng 10–15 30 1–4 mL H
Milk GC-HRMS; GC-MS/MS; HPLC-MS/MS pg–ng 10–15 40 1–10 mL H
VOCs Blood (whole) GC-MSD; GC-HRMS pg 10–20 10–20 5–10 mL M
Breath GC-MSD ng 10–20 20 10–20 mL M
Bioaccumulative metals Blood (whole) ICP-MS ng 10–15 40 1–2 mL L–M
Hair ICP-MS ng 10–15 40 M
Nonbioaccumulative metals Blood (whole) ICP-MS ng 10–15 40 1–2 mL L–M
Urine ICP-MS ng 10–15 40 1–5 mL L–M
Hair ICP-MS ng 10–15 40 M
Abbreviations: GC, gas chromatography; HPLC, high-performance liquid chromatography; HRMS, high-resolution mass spectrometry; MS/MS, tandem mass spectrometry; MSD, mass
selective detector. 
aL, low cost: < $100; M, medium cost: $100–500; H, high cost: > $500.Barr et al.
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analytes that integrate exposure over longer
periods in order to maximize the exposure
information gained on an individual using the
matrices available during a particular life stage.
Another consideration is the quality and
cost of analyses. We should evaluate low-cost
techniques such as immunoassays for some
applications. In addition to requiring smaller
volumes of samples, these analyses are often
less expensive and require less training to effec-
tively perform the analyses. Before using these
less costly techniques, they should be com-
pared with more commonly used techniques
to confirm that quality exposure assessment
information—as rated by the method sensitiv-
ity, accuracy, specificity, and precision—can
be obtained and that the resulting data will be
comparable with data existing in the literature.
Generally, persistent organic chemicals are
measured more readily in blood-based matri-
ces or other lipid-rich matrices. Maternal
measurements serve as good surrogates for
fetal exposures and even early childhood expo-
sures if levels are not reduced by breast-feed-
ing. Assessments of exposure to nonpersistent
chemicals are the most challenging, but they
can be measured in multiple matrix types.
Urine is the most commonly used matrix for
measurement of these chemicals, but inter-
pretation of the information obtained is often
complicated by coexposures, urine dilution,
specificity issues, and the temporality of the
measurement. To date, no ideal way exists to
interpret many of these measurements without
the use of additional measures, for example,
repeat measurements or environmental meas-
urements. Measurements of metals have
been performed in many matrices over the
years and are, in general, well understood.
Biomonitoring will likely have limited utility in
the assessment of exposure to criteria pollutants
and bioallergens.
REFERENCES
Adgate JL, Barr DB, Clayton CA, Eberly LE, Freeman NC, Lioy PJ,
et al. 2001. Measurement of children’s exposure to pesti-
cides: analysis of urinary metabolite levels in a probability-
based sample. Environ Health Perspect 109:583–590.
Angerer J. 1988. Determination of toluene in blood by head-space
gas chromatography. IARC Sci Publ 85:287–291.
Angerer J, Goen T, Kramer A, Kafferlein HU. 1998.
N-Methylcarbamoyl adducts at the N-terminal valine of
globin in workers exposed to N,N-dimethylformamide.
Arch Toxicol 72:309–313.
Angerer J, Horsch B. 1992. Determination of aromatic hydro-
carbons and their metabolites in human blood and urine.
J Chromatogr 580:229–255.
Ashley DL, Bonin MA, Cardinali FL, McCraw JM, Wooten JV.
1994. Blood concentrations of volatile organic compounds
in a nonoccupationally exposed US population and in
groups with suspected exposure. Clin Chem 40:1401–1404.
Aufderheide AC, Wittmers LE Jr. 1992. Selected aspects of the
spatial distribution of lead in bone. Neurotoxicology
13:809–819.
Barr D, Barr J, Maggio V, Whitehead R, Sadowski M, Whyatt R,
et al. 2002. A multi-analyte method for the quantiﬁcation of
contemporary pesticides in human serum and plasma
using high-resolution mass spectrometry. J Chromatogr B
Analyt Technol Biomed Life Sci 778:99–111.
Barr D, Needham L. 2002. Analytical methods for biological moni-
toring of exposure to pesticides: a review. J Chromatogr B
Analyt Technol Biomed Life Sci 778:5–29.
Barr DB, Barr JR, Driskell WJ, Hill RH Jr, Ashley DL, Needham
LL, et al. 1999. Strategies for biological monitoring of expo-
sure for contemporary-use pesticides. Toxicol Ind Health
15:168–179.
Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL,
Pirkle JL. 2005. Urinary creatinine concentrations in the
U.S. population: implications for urinary biologic monitor-
ing measurements. Environ Health Perspect 113:192–200.
Bearer CF. 2003. Meconium as a biological marker of prenatal
exposure. Ambul Pediatr 3:40–43.
Bearer CF, Jacobson JL, Jacobson SW, Barr D, Croxford J,
Molteno CD, et al. 2003. Validation of a new biomarker of
fetal exposure to alcohol. J Pediatr 143:463–469.
Bearer CF, Lee S, Salvator AE, Minnes S, Swick A, Yamashita T,
et al. 1999. Ethyl linoleate in meconium: a biomarker for pre-
natal ethanol exposure. Alcohol Clin Exp Res 23:487–493.
Bernert JT Jr, McGuffey JE, Morrison MA, Pirkle JL. 2000.
Comparison of serum and salivary cotinine measurements
by a sensitive high-performance liquid chromatography-
tandem mass spectrometry method as an indicator of expo-
sure to tobacco smoke among smokers and nonsmokers.
J Anal Toxicol 24:333–339.
Biagini RE, Tolos W, Sanderson WT, Henningsen GM, MacKenzie
B. 1995. Urinary biomonitoring for alachlor exposure in com-
mercial pesticide applicators by immunoassay. Bull Environ
Contam Toxicol 54:245–250.
Blount BC, Silva MJ, Caudill SP, Needham LL, Pirkle JL,
Sampson EJ, et al. 2000. Levels of seven urinary phthalate
metabolites in a human reference population. Environ
Health Perspect 108:972–982.
Bradman A, Barr DB, Claus Henn BG, Drumheller T, Curry C,
Eskenazi B. 2003. Measurement of pesticides and other
toxicants in amniotic ﬂuid as a potential biomarker of pre-
natal exposure: a validation study. Environ Health Perspect
111:1779–1782.
Brady JF, Fleeker JR, Wilson RA, Mumma RO. 1989. Enzyme
immunoassay for aldicarb. In: Biological Monitoring for
Pesticide Exposure: Measurement, Estimation and Risk
Reduction (Wang RG, Franklin CA, Honeycutt RC, Reinert JC,
eds). Washington, DC:American Chemical Society, 262–284.
Calafat AM, Needham LL, Silva M, Lambert GH. 2004. Exposure
to di-(2-ethylhexyl) phthalate among premature neonates in
a neonatal intensive care unit. Pediatrics 113:e429–e434.
Carrer P, Moscato G. 2004. Biological pollution and allergic dis-
eases. G Ital Med Lav Ergon 26:370–374.
CDC.2003. Second National Report on Human Exposure to
Environmental Chemicals. Atlanta, GA:Centers for Disease
Control and Prevention, National Center for Environmental
Health. Available: http://www.cdc.gov/exposurereport
[accessed 5 June 2003].
Chaussabel D. 2004. Biomedical literature mining: challenges
and solutions in the ‘omics’ era. Am J Pharmacogenomics
4:383–393.
de Hoog CL, Mann M. 2004. Proteomics. Annu Rev Genomics
Hum Genet 5:267–293.
Dettmer K, Hammock BD. 2004. Metabolomics—a new exciting
ﬁeld within the “omics” sciences. Environ Health Perspect
112:A396–A397.
Fenske RA, Kissel JC, Lu C, Kalman DA, Simcox NJ, Allen EH,
et al. 2000. Biologically based pesticide dose estimates for
children in an agricultural community. Environ Health
Perspect 108:515–520.
Flesch-Janys D, Becher H, Gurn P, Jung D, Konietzko J, Manz A,
et al. 1996. Elimination of polychlorinated dibenzo-p-dioxins
and dibenzofurans in occupationally exposed persons.
J Toxicol Environ Health 47:363–378.
Foster WG, Chan S, Platt L, Hughes CL Jr. 2002. Detection of
phytoestrogens in samples of second trimester human
amniotic ﬂuid. Toxicol Lett 129:199–205.
Goodman RE, Leach JN. 2004. Assessing the allergenicity of
proteins introduced into genetically modified crops using
speciﬁc human IgE assays. J AOAC Int 87:1423–1432.
Horng CJ, Tsai JL, Lin SR. 1999. Determination of urinary arsenic,
mercury, and selenium in steel production workers. Biol
Trace Elem Res 70:29–40.
Hu Y, Beach J, Raymer J, Gardner M. 2004. Disposable diaper to
collect urine samples from young children for pyrethroid
pesticide studies. J Expo Anal Environ Epidemiol 14:378–384.
Hu YA, Barr DB, Akland G, Melnyk LJ, Needham LL, Pellizzari ED,
et al. 2000. Collecting urine samples from young children
using cotton gauze for pesticide studies. J Expo Anal
Environ Epidemiol 10:703–709.
Jones PD, Hu W, De Coen W, Newsted JL, Giesy JP. 2003.
Binding of perfluorinated fatty acids to serum proteins.
Environ Toxicol Chem 22:2639–2649.
Kiechle FL, Zhang X, Holland-Staley CA. 2004. The -omics era
and its impact. Arch Pathol Lab Med 128:1337–1345.
Kissel JC, Curl CL, Kedan G, Lu C, Griffith W, Barr DB, et al.
2005. Comparison of organophosphorus pesticide metabo-
lite levels in single and multiple daily urine samples col-
lected from preschool children in Washington State.
J Expo Anal Environ Epidemiol 15(2):164–171.
LaKind JS, Berlin CM, Naiman DQ. 2001. Infant exposure to
chemicals in breast milk in the United States: what we
need to learn from a breast milk monitoring program.
Environ Health Perspect 109:75–88.
LaKind JS, Berlin CM, Park CN, Naiman DQ, Gudka NJ. 2000.
Methodology for characterizing distributions of incremental
body burdens of 2,3,7,8-TCDD and DDE from breast milk in
North American nursing infants. J Toxicol Environ Health A
59:605–639.
Lapostolle F, Raynaud PJ, Le Toumelin P, Benaissa A, Agostinucci
JM, Adnet F, et al. 2001. Measurement of carbon monoxide in
expired breath in prehospital management of carbon monox-
ide intoxication. Ann Fr Anesth Reanim 20:10–15.
Lee CH, Chuang HY, Shih CC, Jee SH, Wang LF, Chiu HC, et al.
2004. Correlation of serum total IgE, eosinophil granule
cationic proteins, sensitized allergens and family aggrega-
tion in atopic dermatitis patients with or without rhinitis.
J Dermatol 31:784–793.
Leng G, Kuhn KH, Idel H. 1997. Biological monitoring of
pyrethroids in blood and pyrethroid metabolites in urine:
applications and limitations. Sci Total Environ 199:173–181.
Lin TH, Huang YL, Wang MY. 1998. Arsenic species in drinking
water, hair, ﬁngernails, and urine of patients with blackfoot
disease. J Toxicol Environ Health A 53:85–93.
Lu C, Anderson LC, Morgan MS, Fenske RA. 1998. Salivary con-
centrations of atrazine reﬂect free atrazine plasma levels in
rats. J Toxicol Environ Health A 53:283–292.
Makarananda K, Pengpan U, Srisakulthong M, Yoovathaworn K,
Sriwatanakul K. 1998. Monitoring of aﬂatoxin exposure by
biomarkers. J Toxicol Sci 23(suppl 2):155–159.
Malir F, Ostry V, Cerna M, Kacerovsky J, Roubal T, Skarkova J,
et al. 2004. Monitoring the important mycotoxin biomarkers
(ochratoxin A, aﬂatoxin M1) in the Czech population. Cas Lek
Cesk 143:691–696.
Michalek JE, Pirkle JL, Caudill SP, Tripathi RC, Patterson DG Jr,
Needham LL. 1996. Pharmacokinetics of TCDD in veterans of
Operation Ranch Hand: 10-year follow-up [published erra-
tum J Toxicol Environ Health 52:557]. J Toxicol Environ
Health 47:209–220.
NCS. 2004. Final white paper with executive summary.
Measurement and analysis of exposure to environmental
pollutants and biological agents during the National
Children’s Study. Rockville, MD:The National Children’s
Study. Available: http://www.nationalchildrensstudy.gov/
research/methods_studies/ [accessed 1 March 2005].
NCS. National Children’s Study. 2005. Home page. Rockville,
MD:The National Children’s Study. Available: http://www.
nationalchildrens study.gov/ [accessed 1 March 2005].
Needham LL, Barr DB, Calafat AM. 2004. Characterizing chil-
dren’s exposures: beyond NHANES. Neurotoxicology doi:
10.1016/j.neuro.2004.09.006 [Online 26 Nov 2004].
Needham LL, Sexton K. 2000. Assessing children’s exposure to
hazardous environmental chemicals: an overview of
selected research challenges and complexities. J Expo Anal
Environ Epidemiol 10:611–629.
Needham LL, Özkaynak H, Whyatt RM, Barr DB, Wang RY,
Naeher L, et al. 2005. Exposure assessment in the National
Children’s Study: Introduction. Environ Health Perspect
113(8):1076–1082.
Olden K. 2004. Genomics in environmental health research—
opportunities and challenges. Toxicology 198:19–24.
Ostrea EM Jr. 1999. Testing for exposure to illicit drugs and other
agents in the neonate: a review of laboratory methods and
the role of meconium analysis. Curr Probl Pediatr 29:37–56.
Ostrea EM Jr, Knapp DK, Romero A, Montes M, Ostrea AR. 1994.
Meconium analysis to assess fetal exposure to nicotine by
active and passive maternal smoking. J Pediatr 124:471–476.
Paredi P, Kharitonov SA, Barnes PJ. 2002. Analysis of expired air
for oxidation products. Am J Respir Crit Care Med 166:
S31–S37.
Patterson DG, Jr, Holler JS, Belser WT, Boozer EL, Lapeza CR,Needham LL. 1987. Determination of 2,3,7,8-TCDD in
human adipose tissure on whole-weight and lipid bases.
Chemosphere 16:935-938.
Pellizzari ED, Wallace LA, Gordon SM. 1992. Elimination kinet-
ics of volatile organics in humans using breath measure-
ments. J Expo Anal Environ Epidemiol 2:341–355.
Phillips DL, Pirkle JL, Burse VW, Bernert JT Jr, Henderson LO,
Needham LL. 1989a. Chlorinated hydrocarbon levels in
human serum: effects of fasting and feeding. Arch Environ
Contam Toxicol 18:495–500.
Phillips DL, Smith AB, Burse VW, Steele GK, Needham LL, Hannon
WH. 1989b. Half-life of polychlorinated biphenyls in occupa-
tionally exposed workers. Arch Environ Health 44:351–354.
Pirkle JL, Needham LL, Sexton K. 1995. Improving exposure
assessment by monitoring human tissues for toxic chemi-
cals. J Expo Anal Environ Epidemiol 5:405–424.
Pirkle JL, Wolfe WH, Patterson DG, Needham LL, Michalek JE,
Miner JC, et al. 1989. Estimates of the half-life of 2,3,7,8-tetra-
chlorodibenzo-p-dioxin in Vietnam Veterans of Operation
Ranch Hand. J Toxicol Environ Health 27:165–171.
Rozman KK, Klaasen CD. 2001. Absorption, distribution and
excretion of toxicants. In: Casarett and Doull’s Toxicology:
The Basic Science of Poisons (Klaassen CD, ed). 6th ed.
New York:McGraw-Hill Publishing, 107–132
Schettgen T, Broding HC, Angerer J, Drexler H. 2002. Hemoglobin
adducts of ethylene oxide, propylene oxide, acrylonitrile and
acrylamide-biomarkers in occupational and environmental
medicine. Toxicol Lett 134:65–70.
Sexton K, Callahan MA, Bryan EF. 1995. Estimating exposure and
dose to characterize health risks: the role of human tissue
monitoring in exposure assessment. Environ Health Perspect
103(suppl 3):13–29.
Shenoi R, Stewart G, Rosenberg N. 1998. Screening for carbon
monoxide in children. Pediatr Emerg Care 14:399–402.
Smith CJ, Guy TD, Stiles MF, Morton MJ, Collie BB, Ingebrethsen
BJ, et al. 1998. A repeatable method for determination of car-
boxyhemoglobin levels in smokers. Hum Exp Toxicol 17:29–34.
United Nations Environment Program. 2001. Final Act of the
Conference of Plenipotentiaries on Stockholm Convention
on Persistent Organic Pollutants. Available: http://www.
[accessed 4 March 2005].
Wetmore BA, Merrick BA. 2004. Toxicoproteomics: proteomics
applied to toxicology and pathology. Toxicol Pathol 32:
619–642.
Whyatt RM, Barr DB. 2001. Measurement of organophosphate
metabolites in postpartum meconium as a potential bio-
marker of prenatal exposure: a validation study. Environ
Health Perspect 109:417–420.
Wilhelm M, Idel H. 1996. Hair analysis in environmental medi-
cine. Zentralbl Hyg Umweltmed 198:485–501.
Biomonitoring during the life stages
Environmental Health Perspectives • VOLUME 113 | NUMBER 8 | August 2005 1091
chem.unep.ch/pops/POPs_Inc/dipcon/dipconsignat.htm